Modeling amyloids in bacteria

Microbial Cell Factories

Volumn 11, Issue , 2012, Pages

  Villar Piqué, Anna ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN;

ALZHEIMER DISEASE; BACTERIAL CELL; CHEMICAL STRUCTURE; COST; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; NOTE; PARKINSON DISEASE; PATHOLOGY; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

AMYLOID; BACTERIA; INCLUSION BODIES; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; PRIONS; THIAZOLES;

BACTERIA (MICROORGANISMS);

EID: 84872185872     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-11-166     Document Type: Note

References (34)

1. Fernandez-Busquets X, de Groot NS, Fernandez D, Ventura S. Recent structural and computational insights into conformational diseases. Curr Med Chem 2008, 15:1336-1349. 10.2174/092986708784534938, 18537613.
2. Invernizzi G, Papaleo E, Sabate R, Ventura S. Protein aggregation: mechanisms and functional consequences. Int J Biochem Cell Biol 2012, 44:1541-1554. 10.1016/j.biocel.2012.05.023, 22713792.
3. Sorensen HP, Mortensen KK. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 2005, 4:1. 10.1186/1475-2859-4-1, 544838, 15629064.
4. Jurgen B, Breitenstein A, Urlacher V, Buttner K, Lin H, Hecker M, Schweder T, Neubauer P. Quality control of inclusion bodies in Escherichia coli. Microb Cell Fact 2010, 9:41. 10.1186/1475-2859-9-41, 2893105, 20509924.
5. Ventura S. Sequence determinants of protein aggregation: tools to increase protein solubility. Microb Cell Fact 2005, 4:11. 10.1186/1475-2859-4-11, 1087874, 15847694.
6. Ventura S, Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol 2006, 24:179-185. 10.1016/j.tibtech.2006.02.007, 16503059.
7. de Groot NS, Sabate R, Ventura S. Amyloids in bacterial inclusion bodies. Trends Biochem Sci 2009, 34:408-416. 10.1016/j.tibs.2009.03.009, 19647433.
8. Garcia-Fruitos E, Sabate R, de Groot NS, Villaverde A, Ventura S. Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J 2011, 278:2419-2427. 10.1111/j.1742-4658.2011.08165.x, 21569209.
9. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S. Amyloid-like properties of bacterial inclusion bodies. J Mol Biol 2005, 347:1025-1037. 10.1016/j.jmb.2005.02.030, 15784261.
10. Morell M, Bravo R, Espargaro A, Sisquella X, Aviles FX, Fernandez-Busquets X, Ventura S. Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim Biophys Acta 2008, 1783:1815-1825. 10.1016/j.bbamcr.2008.06.007, 18619498.
11. Wang L, Maji SK, Sawaya MR, Eisenberg D, Riek R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol 2008, 6:e195. 10.1371/journal.pbio.0060195, 2494559, 18684013.
12. Wasmer C, Benkemoun L, Sabate R, Steinmetz MO, Coulary-Salin B, Wang L, Riek R, Saupe SJ, Meier BH. Solid-state NMR spectroscopy reveals that E. coli inclusion bodies of HET-s(218-289) are amyloids. Angew Chem Int Ed Engl 2009, 48:4858-4860. 10.1002/anie.200806100, 19472238.
13. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, Aris A, Ventura S, Villaverde A. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 2005, 4:27. 10.1186/1475-2859-4-27, 1224866, 16156893.
14. Garcia-Fruitos E, Aris A, Villaverde A. Localization of functional polypeptides in bacterial inclusion bodies. Appl Environ Microbiol 2007, 73:289-294. 10.1128/AEM.01952-06, 1797118, 17085715.
15. de Groot NS, Ventura S. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J Biotechnol 2006, 125:110-113. 10.1016/j.jbiotec.2006.02.026, 16621081.
16. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact 2008, 7:34. 10.1186/1475-2859-7-34, 2630956, 19046444.
17. Wu W, Xing L, Zhou B, Lin Z. Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb Cell Fact 2011, 10:9. 10.1186/1475-2859-10-9, 3045283, 21320350.
18. Garcia-Fruitos E. Inclusion bodies: a new concept. Microb Cell Fact 2010, 9:80. 10.1186/1475-2859-9-80, 2987918, 21040537.
19. Garcia-Fruitos E, Vazquez E, Diez-Gil C, Corchero JL, Seras-Franzoso J, Ratera I, Veciana J, Villaverde A. Bacterial inclusion bodies: making gold from waste. Trends Biotechnol 2012, 30:65-70. 10.1016/j.tibtech.2011.09.003, 22037492.
20. Peternel S, Komel R. Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells. Microb Cell Fact 2010, 9:66. 10.1186/1475-2859-9-66, 2944166, 20831775.
21. Rodriguez-Carmona E, Cano-Garrido O, Seras-Franzoso J, Villaverde A, Garcia-Fruitos E. Isolation of cell-free bacterial inclusion bodies. Microb Cell Fact 2010, 9:71. 10.1186/1475-2859-9-71, 2949796, 20849629.
22. Vazquez E, Corchero JL, Burgueno JF, Seras-Franzoso J, Kosoy A, Bosser R, Mendoza R, Martinez-Lainez JM, Rinas U, Fernandez E, et al. Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv Mater 2012, 24:1742-1747. 10.1002/adma.201104330, 22410789.
23. Villaverde A, Garcia-Fruitos E, Rinas U, Seras-Franzoso J, Kosoy A, Corchero JL, Vazquez E. Packaging protein drugs as bacterial inclusion bodies for therapeutic applications. Microb Cell Fact 2012, 11:76.
24. Gonzalez-Montalban N, Villaverde A, Aris A. Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies. Biochem Biophys Res Commun 2007, 355:637-642. 10.1016/j.bbrc.2007.01.192, 17307135.
25. Dasari M, Espargaro A, Sabate R, del Amo JM L, Fink U, Grelle G, Bieschke J, Ventura S, Reif B. Bacterial inclusion bodies of Alzheimer's disease beta-amyloid peptides can be employed to study native-like aggregation intermediate states. Chembiochem 2011, 12:407-423. 10.1002/cbic.201000602, 21290543.
26. Sabate R, Espargaro A, Saupe SJ, Ventura S. Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion. Microb Cell Fact 2009, 8:56. 10.1186/1475-2859-8-56, 2774669, 19863787.
27. Espargaro A, Villar-Pique A, Sabate R, Ventura S. Yeast prions form infectious amyloid inclusion bodies in bacteria. Microb Cell Fact 2012, 11:89. 10.1186/1475-2859-11-89, 3520751, 22731490.
28. Sivanathan V, Hochschild A. Generating extracellular amyloid aggregates using E. coli cells. Genes Dev 2012, 26:2659-2667. 10.1101/gad.205310.112, 23166018.
29. Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009, 89:1105-1152. 10.1152/physrev.00006.2009, 19789378.
30. Waldo GS, Standish BM, Berendzen J, Terwilliger TC. Rapid protein-folding assay using green fluorescent protein. Nat Biotechnol 1999, 17:691-695. 10.1038/10904, 10404163.
31. Villar-Pique A, de Groot NS, Sabate R, Acebron SP, Celaya G, Fernandez-Busquets X, Muga A, Ventura S. The effect of amyloidogenic peptides on bacterial aging correlates with their intrinsic aggregation propensity. J Mol Biol 2012, 421:270-281. 10.1016/j.jmb.2011.12.014, 22200483.
32. Kim W, Kim Y, Min J, Kim DJ, Chang YT, Hecht MH. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. ACS Chem Biol 2006, 1:461-469. 10.1021/cb600135w, 17168524.
33. Villar-Pique A, Espargaro A, Sabate R, de Groot NS, Ventura S. Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb Cell Fact 2012, 11:55. 10.1186/1475-2859-11-55, 3495732, 22553999.
34. Espargaro A, Sabate R, Ventura S. Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation. Mol Biosyst 2012, 8:2839-2844. 10.1039/c2mb25214g, 22868714.